Archana Ray

Statistics

Publications

Citations

619

H-Index

Active since

2015

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Sheba Medical Center

Aichi Cancer Center

Moffitt Cancer Center

Tel Aviv Sourasky Medical Center

Archana Ray is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in oncology, medicine, and immunotherapy for gastric cancer.

Publications per year

2015–2018

Publications

Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012

Ranee Mehra, Tanguy Y. Seiwert, Shilpa Gupta et al. · British Journal of Cancer · 2018 · 456 citations · Full text

Medicine, Oncology, Oncology Pharmacotherapy +2

Relationship between PD-L1 expression and clinical outcomes in patients (Pts) with advanced gastric cancer treated with the anti-PD-1 monoclonal antibody pembrolizumab (Pembro; MK-3475) in KEYNOTE-012.

Kei Muro, Yung‐Jue Bang, Veena Shankaran et al. · Journal of Clinical Oncology · 2015 · 118 citations

Medicine, Oncology, Pharmacology +17

Relationship between PD-L1 expression and clinical outcomes in patients with advanced gastric cancer treated with the anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) in KEYNOTE-012.

Yung‐Jue Bang, Hyun-Choel Chung, Veena Shankaran et al. · Journal of Clinical Oncology · 2015 · 45 citations

Medicine, Oncology, Pharmacotherapy +17

1–3 of 3